Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Application of a nanotechnology antimicrobial spray to prevent lower urinary tract infection: a multicenter urology trial.

He W, Wang D, Ye Z, Qian W, Tao Y, Shi X, Liu L, Chen J, Qiu L, Wan P, Jia X, Li X, Gao C, Ma X, Wen B, Chen N, Li P, Ren Z, Lan L, Li S, Zuo Y, Zhang H, Ma L, Zhang Y, Li Z, Su W, Yang Q, Chen Q, Wang X, Ye Z, Chen JP, Loo WT, Chow LW, Yip AY, Ng EL, Cheung MN, Wang Z.

J Transl Med. 2012 Sep 19;10 Suppl 1:S14. doi: 10.1186/1479-5876-10-S1-S14. Epub 2012 Sep 19.

2.

In vitro comparison of nitrofurazone- and silver alloy-coated foley catheters for contact-dependent and diffusible inhibition of urinary tract infection-associated microorganisms.

Johnson JR, Johnston B, Kuskowski MA.

Antimicrob Agents Chemother. 2012 Sep;56(9):4969-72. doi: 10.1128/AAC.00733-12. Epub 2012 Jul 2.

3.

Silver or nitrofurazone impregnation of urinary catheters has a minimal effect on uropathogen adherence.

Desai DG, Liao KS, Cevallos ME, Trautner BW.

J Urol. 2010 Dec;184(6):2565-71. doi: 10.1016/j.juro.2010.07.036.

4.

Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Jacobsen SM, Stickler DJ, Mobley HL, Shirtliff ME.

Clin Microbiol Rev. 2008 Jan;21(1):26-59. doi: 10.1128/CMR.00019-07. Review.

5.

Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.

Burton E, Gawande PV, Yakandawala N, LoVetri K, Zhanel GG, Romeo T, Friesen AD, Madhyastha S.

Antimicrob Agents Chemother. 2006 May;50(5):1835-40.

6.

Biofilms: survival mechanisms of clinically relevant microorganisms.

Donlan RM, Costerton JW.

Clin Microbiol Rev. 2002 Apr;15(2):167-93. Review.

Supplemental Content

Support Center